S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.18 CNY -1.64% Market Closed
Market Cap: 34.8B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Relative Value

The Relative Value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 33.56 CNY. Compared to the current market price of 31.18 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
33.56 CNY
Undervaluation 7%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
49
vs Industry
17
Median 3Y
9.6
Median 5Y
9.6
Industry
2.6
Forward
8.3
vs History
42
vs Industry
7
Median 3Y
55.5
Median 5Y
56.1
Industry
23
Forward
53
vs History
36
vs Industry
13
Median 3Y
33.7
Median 5Y
29.6
Industry
17.8
vs History
17
vs Industry
3
Median 3Y
135.6
Median 5Y
72.8
Industry
25.4
vs History
33
vs Industry
19
Median 3Y
4
Median 5Y
4.1
Industry
2.2
vs History
52
vs Industry
16
Median 3Y
9
Median 5Y
9
Industry
2.8
Forward
7.8
vs History
49
vs Industry
15
Median 3Y
13.1
Median 5Y
13.1
Industry
5.4
vs History
53
vs Industry
6
Median 3Y
55.6
Median 5Y
56.6
Industry
13.7
Forward
31.1
vs History
53
vs Industry
7
Median 3Y
55.6
Median 5Y
56.6
Industry
17.2
Forward
49.9
vs History
34
vs Industry
13
Median 3Y
31.8
Median 5Y
27.2
Industry
16.5
vs History
19
vs Industry
3
Median 3Y
88.6
Median 5Y
64.3
Industry
19.3
vs History
41
vs Industry
19
Median 3Y
4.3
Median 5Y
4.4
Industry
2

Multiples Across Competitors

Competitors Multiples
Shenzhen Salubris Pharmaceuticals Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
34B CNY 9.1 58 52.9 52.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6

See Also

Discover More
Back to Top